Do you want to read an article? Please log in or register.
Diode-Pumped Laser for Lung-Sparing Surgical Treatment of Malignant Pleural Mesothelioma
Lung, Respiratory and Thoracic CancerRadio-Oncology
Related content
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trial
Lancet Respir Med.
Disselhorst MJ, Quispel-Janssen J, Lalezari F, Monkhorst K, de Vries JF, van der Noort V, Harms E, Burgers S, Baas P
doi: 10.1016/S2213-2600(18)30420-X.
Lung, Respiratory and Thoracic CancerRadio-Oncology
Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial
Lancet Oncol.
Clive AO, Taylor H, Dobson L, Wilson P, de Winton E, Panakis N, Pepperell J, Howell T, Stewart SA, Penz E, Jordan N, Morley AJ, Zahan-Evans N, Smith S, Batchelor TJ, Marchbank A, Bishop L, Ionescu AA, Bayne M, Cooper S, Kerry A, Jenkins P, Toy E, Vigneswaran V, Gildersleve J, Ahmed M, McDonald F, Button M, Lewanski C, Comins C, Dakshinamoorthy M, Lee YC, Rahman NM, Maskell NA
doi: 10.1016/
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial
Lancet Oncol.
Ceresoli GL, Aerts JG, Dziadziuszko R, Ramlau R, Cedres S, van Meerbeeck JP, Mencoboni M, Planchard D, Chella A, Crinò L, Krzakowski M, Rüssel J, Maconi A, Gianoncelli L, Grosso F
doi: 10.1016/S1470-2045(19)30532-7.
Lung, Respiratory and Thoracic Cancer
Pembrolizumab as Palliative Immunotherapy in Malignant Pleural Mesothelioma
doi: 10.1016/j.jtho.2018.08.007.
Lung, Respiratory and Thoracic CancerRadio-Oncology
Radiologic Considerations And Standardization Of Malignant Pleural Mesothelioma (MPM) Imaging Within Clinical Trials: Consensus Statement From The NCI Thoracic Malignancy Steering Committee - International Association For The Study Of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting
J Thorac Oncol.
Gill RR, Tsao AS, Kindler HL, Richards WG, Armato SG 3rd, Francis RJ, Gomez DR, Dahlberg S, Rimner A, Simone CB 2nd, de Perrot M, Blumenthal G, Adjei AA, Bueno R, Harpole DH Jr, Hesdorffer M, Hirsch FR, Pass HI, Yorke E, Rosenzweig K, Burt B, Fennell DA, Lindwasser W, Malik S, Peikert T, Mansfield AS, Salgia R, Yang H, Rusch VW, Nowak AK
doi: 10.1016/j.jtho.2019.08.012.
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial
★ 1
Recommended by
Dr Wolf-Dieter Janthur, Faculty Member
Lancet Oncol
Pinto C, Zucali PA, Pagano M, Grosso F, Pasello G, Garassino MC, Tiseo M, Soto Parra H, Grossi F, Cappuzzo F, de Marinis F, Pedrazzoli P, Bonomi M, Gianoncelli L, Perrino M, Santoro A, Zanelli F, Bonelli C, Maconi A, Frega S, Gervasi E, Boni L, Ceresoli GL
doi: 10.1016/S1470-2045(21)00404-6
Lung, Respiratory and Thoracic Cancer
Differential Diagnosis of Epithelioid Malignant Mesothelioma With Lung and Breast Pleural Metastasis: A Systematic Review Compared With a Standardized Panel of Antibodies-A New Proposal That May Influence Pathologic Practice
Arch Pathol Lab Med.
Le Stang N, Burke L, Blaizot G, Gibbs AR, Lebailly P, Clin B, Girard N, Galateau-Sallé F, MESOPATH and EURACAN networks.
doi: 10.5858/arpa.2018-0457-OA.
Lung, Respiratory and Thoracic Cancer
Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma
J Thorac Oncol.
Kao SC, Cheng YY, Williams M, Kirschner MB, Madore J, Lum T, Sarun KH, Linton A, McCaughan B, Klebe S, van Zandwijk N, Scolyer RA, Boyer MJ, Cooper WA, Reid G
doi: 10.1016/j.jtho.2017.05.024.
Lung, Respiratory and Thoracic Cancer
Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease
BMC Cancer.
Collins DC, Sundar R, Constantidinou A, Dolling D, Yap TA, Popat S, O'Brien ME, Banerji U, de Bono JS, Lopez JS, Tunariu N, Minchom A
doi: 10.1186/s12885-020-07662-y.